JPWO2019215333A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019215333A5 JPWO2019215333A5 JP2021513004A JP2021513004A JPWO2019215333A5 JP WO2019215333 A5 JPWO2019215333 A5 JP WO2019215333A5 JP 2021513004 A JP2021513004 A JP 2021513004A JP 2021513004 A JP2021513004 A JP 2021513004A JP WO2019215333 A5 JPWO2019215333 A5 JP WO2019215333A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- group
- lipid
- lipid group
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862670319P | 2018-05-11 | 2018-05-11 | |
| US62/670,319 | 2018-05-11 | ||
| PCT/EP2019/062064 WO2019215333A1 (en) | 2018-05-11 | 2019-05-10 | Oligonucleotides conjugates comprising 7'-5'-alpha-anomeric-bicyclic sugar nucleosides |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021522862A JP2021522862A (ja) | 2021-09-02 |
| JP2021522862A5 JP2021522862A5 (https=) | 2024-06-07 |
| JPWO2019215333A5 true JPWO2019215333A5 (https=) | 2024-06-07 |
| JP7665509B2 JP7665509B2 (ja) | 2025-04-21 |
Family
ID=66530048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513004A Active JP7665509B2 (ja) | 2018-05-11 | 2019-05-10 | ７’－５’－アルファ－アノマー二環式糖ヌクレオシドを含むオリゴヌクレオチドコンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20230132377A9 (https=) |
| EP (1) | EP3790968A1 (https=) |
| JP (1) | JP7665509B2 (https=) |
| KR (1) | KR20210008369A (https=) |
| CN (1) | CN112424352A (https=) |
| AU (1) | AU2019266550A1 (https=) |
| BR (1) | BR112020022620A2 (https=) |
| CA (1) | CA3098266A1 (https=) |
| SG (1) | SG11202010841QA (https=) |
| WO (1) | WO2019215333A1 (https=) |
| ZA (1) | ZA202007564B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3330276A1 (en) * | 2016-11-30 | 2018-06-06 | Universität Bern | Novel bicyclic nucleosides and oligomers prepared therefrom |
| WO2019217459A1 (en) | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| EP3829595A4 (en) | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| US20220370491A1 (en) * | 2019-09-18 | 2022-11-24 | National University Corporation Tokyo Medical And Dental University | Nucleic acid complex |
| EP4213883A1 (en) * | 2020-09-16 | 2023-07-26 | Astrazeneca AB | Oligonucleotides conjugated to fatty acids |
| WO2022106695A1 (en) | 2020-11-23 | 2022-05-27 | Alpha Anomeric Sas | Nucleic acid duplexes |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| IL309936A (en) | 2021-07-09 | 2024-03-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of dystrophinopathy |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| CN120225676A (zh) | 2022-12-02 | 2025-06-27 | 上海舶望制药有限公司 | 双环脱碱基核酸类似物以及由它们制备的寡聚化合物 |
| WO2025217304A1 (en) * | 2024-04-09 | 2025-10-16 | Bio-Rad Laboratories, Inc. | Compositions and methods for detection of contaminant enzymes |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687808A (en) | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| ATE162219T1 (de) | 1989-11-16 | 1998-01-15 | Univ Duke | Transformation von tierischen hautzellen mit hilfe von partikeln |
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| JP3257675B2 (ja) | 1990-10-12 | 2002-02-18 | マックス−プランク−ゲゼルシャフト ツール フェルデルング デル ビッセンシャフテン エー．ファウ． | 修飾リボザイム |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US6020317A (en) | 1993-02-19 | 2000-02-01 | Nippon Shinyaku Co. Ltd. | Glycerol derivative, device and pharmaceutical composition |
| TW404844B (en) | 1993-04-08 | 2000-09-11 | Oxford Biosciences Ltd | Needleless syringe |
| US5994316A (en) | 1996-02-21 | 1999-11-30 | The Immune Response Corporation | Method of preparing polynucleotide-carrier complexes for delivery to cells |
| US6218108B1 (en) | 1997-05-16 | 2001-04-17 | Research Corporation Technologies, Inc. | Nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
| US6042820A (en) | 1996-12-20 | 2000-03-28 | Connaught Laboratories Limited | Biodegradable copolymer containing α-hydroxy acid and α-amino acid units |
| US6248878B1 (en) | 1996-12-24 | 2001-06-19 | Ribozyme Pharmaceuticals, Inc. | Nucleoside analogs |
| US6472375B1 (en) | 1998-04-16 | 2002-10-29 | John Wayne Cancer Institute | DNA vaccine and methods for its use |
| JP2000325085A (ja) * | 1999-05-21 | 2000-11-28 | Masafumi Matsuo | デュシェンヌ型筋ジストロフィー治療剤 |
| US6653467B1 (en) * | 2000-04-26 | 2003-11-25 | Jcr Pharmaceutical Co., Ltd. | Medicament for treatment of Duchenne muscular dystrophy |
| CA2524255C (en) * | 2003-03-21 | 2014-02-11 | Academisch Ziekenhuis Leiden | Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| US20080213891A1 (en) | 2004-07-21 | 2008-09-04 | Alnylam Pharmaceuticals, Inc. | RNAi Agents Comprising Universal Nucleobases |
| WO2007030167A1 (en) | 2005-09-02 | 2007-03-15 | Nastech Pharmaceutical Company Inc. | Modification of double-stranded ribonucleic acid molecules |
| EP2666859B1 (en) * | 2006-04-03 | 2019-01-02 | Roche Innovation Center Copenhagen A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| WO2010036698A1 (en) * | 2008-09-24 | 2010-04-01 | Isis Pharmaceuticals, Inc. | Substituted alpha-l-bicyclic nucleosides |
| KR20200133284A (ko) | 2010-05-28 | 2020-11-26 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | 변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체 |
| US10077443B2 (en) * | 2012-11-15 | 2018-09-18 | Roche Innovation Center Copenhagen A/S | Oligonucleotide conjugates |
| CN104955952A (zh) * | 2013-01-30 | 2015-09-30 | 弗·哈夫曼-拉罗切有限公司 | Lna寡核苷酸碳水化合物缀合物 |
| CN106581043A (zh) * | 2016-10-24 | 2017-04-26 | 佳木斯大学 | 一种适用于杜氏肌营养不良症的药物制剂及其制备方法 |
| EP3330276A1 (en) * | 2016-11-30 | 2018-06-06 | Universität Bern | Novel bicyclic nucleosides and oligomers prepared therefrom |
-
2019
- 2019-05-10 CA CA3098266A patent/CA3098266A1/en active Pending
- 2019-05-10 US US17/054,724 patent/US20230132377A9/en not_active Abandoned
- 2019-05-10 JP JP2021513004A patent/JP7665509B2/ja active Active
- 2019-05-10 WO PCT/EP2019/062064 patent/WO2019215333A1/en not_active Ceased
- 2019-05-10 CN CN201980046260.3A patent/CN112424352A/zh active Pending
- 2019-05-10 KR KR1020207034385A patent/KR20210008369A/ko not_active Ceased
- 2019-05-10 EP EP19723781.1A patent/EP3790968A1/en active Pending
- 2019-05-10 AU AU2019266550A patent/AU2019266550A1/en not_active Abandoned
- 2019-05-10 SG SG11202010841QA patent/SG11202010841QA/en unknown
- 2019-05-10 BR BR112020022620-3A patent/BR112020022620A2/pt not_active IP Right Cessation
-
2020
- 2020-12-04 ZA ZA2020/07564A patent/ZA202007564B/en unknown
-
2024
- 2024-09-10 US US18/830,182 patent/US20250250565A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019215333A5 (https=) | ||
| JP7740719B2 (ja) | ホスホルアミダイト化学を使用する骨格修飾モルホリノオリゴヌクレオチド及びキメラの合成 | |
| JP2024056718A5 (https=) | ||
| JP2022173349A5 (https=) | ||
| JP2898750B2 (ja) | 有機リン化合物をイオウ化するための方法およびそのための試薬 | |
| CN1964967B (zh) | 路易斯酸介导的环状酯的合成 | |
| JP6632605B2 (ja) | 修飾オリゴヌクレオチドおよびそれらの合成のための方法 | |
| JP2025041652A5 (https=) | ||
| US6084082A (en) | Lactam nucleic acids | |
| Wada et al. | Chemical synthesis of oligodeoxyribonucleotides using N-unprotected H-phosphonate monomers and carbonium and phosphonium condensing reagents: O-selective phosphonylation and condensation | |
| JP2020011932A (ja) | アルコキシフェニル誘導体、ヌクレオシド保護体およびヌクレオチド保護体、オリゴヌクレオチド製造方法、ならびに、置換基除去方法 | |
| JP5995855B2 (ja) | 塩基修飾オリゴヌクレオチド | |
| JP2021533804A5 (https=) | ||
| JP6542662B2 (ja) | オリゴヌクレオチドアナログのボロン酸結合体 | |
| AU2011257980A1 (en) | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups | |
| JPWO2020118246A5 (https=) | ||
| AU2016334232A1 (en) | Oligonucleotide compositions and methods thereof | |
| JP2004500330A (ja) | グアニジニウム官能化オリゴマーとその製造法 | |
| JPWO2005092909A1 (ja) | 立体規則性の高いリボヌクレオチド類縁体及びデオキシリボヌクレオチド類縁体の製造法 | |
| Varma | Synthesis of oligonucleotide analogues with modified backbones | |
| JP2023541415A (ja) | 治療薬の送達用脂質複合体 | |
| JP2017514479A5 (https=) | ||
| CZ19094A3 (en) | Modified oligodeoxyribonucleotides, process of their preparation and pharmaceutical preparations in which they are comprised | |
| JP2018518167A5 (https=) | ||
| Michalski et al. | State of the art. Chemical synthesis of biophosphates and their analogues via PIII derivatives |